1. Morozov, I.S., Artsimovich, I.G., and Fadeeva, T.A., Soviet Union Patent No. 1826906, Byull. Izobr., 1993. 25. 97.

2. Vakhitova, Yu.V., Yamidanov, R.S., and Seredenin, S.B., Ladasten Induces Expression of the Genes, Governing Dopamine Biosynthesis in Various Rat Brain Structures, Eksper. Klin. Farmakol., 2004, vol. 67, no. 4, pp. 7–11.

3. Kumer, S.C. and Vrana, E.K., Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression, J. Neurochem., 1996, vol. 67, pp. 443–462.

4. Yang, C., Kim, H.S., Seo, H., et al., Identification and Characterization of Potential cis-Regulatory Elements Governing Transcriptional Activation of the Rat Tyrosine Hydroxylase Gene, J. Neurochem., 1998, vol. 71, pp. 1358–1368.

5. Nagamoto-Combs, K., Piech, K.M., Best, J.A., et al., Tyrosine Hydroxylase Gene Promoter Activity Is Regulated by Both Cyclic AMP-Responsive Element and AP 1 Sites Following Calcium Influx, J. Biol. Chem., 1997, vol. 272, pp. 6051–6058.

6. Kim, K.S., Kim, C.U., Hwang, D.Y., et al., The Orphan Nuclear Receptor Nurr1 Directly Transactivates the Promoter of the Tyrosine Hydroxylase Gene, but the Dopamine β-Hydroxylase Gene, in a Cell-Specific Manner, J. Neurochem., 2003, vol. 85, pp. 622–634.

7. Okuse, K., Matsuoka, J., and Kurihara, K., Tissue-Specific Methylation Occurs in the Essential Promoter Element of the Tyrosine Hydroxylase Gene, Mol. Brain Res., 1997, vol. 46, pp. 197–207.

8. Vanyushin, B.F., Enzymatic DNA Methylation—Epigenetic Control of Genetic Cell Functions, Biokhimiya, 2005, vol. 70, no. 5, pp. 598–611.

9. Attwood, J.T., Yung, R.L., and Richardson, B.C., DNA Methylation and the Regulation of Gene Transcription, Cell Mol. Life Sci., 2002, vol. 59, pp. 241–257.

10. Razin, A., CpG Methylation, Chromatin Structure and Gene Silencing—a Three-Way Connection, EMBO J., 1998, vol. 17, pp. 4905–4908.

11. Nan, X., Ng, H.H., Johnson, C.A., et al., Transcriptional Repression by the Methyl-CpG-Binding Protein MeCP2 Involves a Histone Deacetylase Complex, Nature, 1998, vol. 393, pp. 386–389.

12. Prendergast, G.C. and Ziff, E.B., Methylation-Sensitive Sequence-Specific DNA Binding by the c-Myc Basic Region, Science, 1991, vol. 251, pp. 186–189.

13. Ramchandani S., Bhattacharya S.K., Cervoni N., et al., DNA Methylation Is a Reversible Biological Signal, Proc. Natl Acad. Sci. USA., 1999. vol. 96. pp. 6107–6112.

14. Cardoso, M.C. and Leonhardt, H., DNA Methyltransferase Is Actively Retained in the Cytoplasm during Early Development, J. Cell Biol., 1999, vol. 147, pp. 25–32.

15. Shyf, M., Methylation and Demethylation of DNA as a Target of Anticancer Therapy, Biokhimiya, 2005, vol. 70, no. 5, pp. 651–669.

16. Zhu, B., Benjamin, D., Zheng, Y., et al., Overexpression of 5-Methylcytosine DNA Glycosylase in Human Embryonic Kidney Cells EcR293 Demethylates the Promoter of a Hormone-Regulated Reporter Gene, Proc. Natl Acad. Sci. USA., 2001, vol. 98, pp. 5031–5036.

17. Detich, N., Theberge, J., and Szyf, M., Promoter-Specific Activation and Demethylation by MBD2/Demethylase, J. Biol. Chem., 2002, vol. 277, no. 39, pp. 35791–35794.

18. Chiurazzi, P. and Neri, G., Pharmacological Reactivation of Inactive Genes: The Fragile X Experience, Brain Res. Bull, 2001, vol. 56, nos. 3–4, pp. 383–387.

19. Nyce, J.W., Drug-Induced DNA Hypermethylation: A Potential Mediator of Acquired Drug Resistance during Cancer Chemotherapy, Mutat. Res., 1997, vol. 386, pp. 153–161.

20. Wyczechowska, D. and Fabianowska-Majewska, K.V., The Effects of Cladribine and Fludarabine on DNA Methylation in K522 Cells, Biochem. Pharmacol., 2003, vol. 65, pp. 219–225.

21. Villar-Garea, A. and Esteller, M., DNA Demethylating Agents and Chromatin-Remodelling Drugs: Which, How and Why?, Curr. Drug Metab., 2003, vol. 4, no. 1, pp. 11–31.

22. Morozov, I.S., Petrov, V.I., and Sergeeva, S.A., Farmakologiya adamantanov (Pharmacology of Adamantanes), Volgograd, 2001.

23. Sambrook, J., Fritsch, E., and Maniatis, T., Molecular Cloning: A Laboratory Manual, New York: Cold Spring Harbor Lab., 1989.

24. Frommer, M., McDonald, L., Millar, D., et al., A Genomic Sequencing Protocol That Yields a Positive Display of 5-Methylcytosine Residues in Individual DNA Strands, Proc. Natl. Acad. Sci. USA, 1992, vol. 89, pp. 1827–1831.

25. Bender, C.M., Zingg, J.-M., and Jones, P.A., DNA Methylation As a Target for Drug Design, Pharm. Res, 1998, vol. 15, pp. 175–187.

26. Szyf, M., Towards a Pharmacology of DNA Methylation, TRENDS Pharm. Sci, 2001, vol. 22, pp. 350–354.

27. Lin, X., Asgari, K., Putzi, M.J., et al., Reversal of GSTP1 CpG Island Hypermethylation and Reactivation of GSTP1 Expression in Human Prostate Cancer Cells by Treatment with Procainamide, Cancer Res., 2001, vol. 61, pp. 8611–8616.

28. Zambrano, P., Segura-Pacheco, B., Perez-Cardenas, E., et al., A Phase I Study of Hydralazine To Demethylate and Reactivate the Expression of Tumor Suppressor Genes, BMC Cancer, 2005, vol. 5, p. 1186.

29. Lee, W.S., Shim, J.Y., and Zhu, B.T., Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids, Mol. Pharmacol., 2005, vol. 68, no. 4, pp. 1018–1030.

30. Lee, W.S. and Zhu, B.T., Inhibition of DNA Methylation by Caffeic Acid and Chlorogenic Acid, Two Common Catechol-Containing Coffee Polyphenols, Carcinogenesis, 2006, vol. 27, pp. 269–277.

31. Marks, P.A., Richon, V.M., Breslow, R., et al., Histone Deacetylase Inhibitors as New Cancer Drugs, Curr. Opin. Oncol., 2001, vol. 13, pp. 477–483.

32. Detich, N., Bovenzi, V., and Szif, M., Valproate Induces Replication—Independent Active DNA Demethylation, J. Biol. Chem., 2003, vol. 278, pp. 27586–27592.

33. Kim, H.-S., Park, J.-S., Hong, S.-J., et al., Regulation of the Tyrosine Hydroxylase Gene Promoter by Histone Deacetylase Inhibitors, Biochem. Biophys. Res. Commun., 2003, vol. 312, no. 4, pp. 950–995.

34. Cervoni, N. and Szyf, M., Demethylase Activity Is Directed by Histone Acetylation, J. Biol. Chem., 2001, vol. 276, pp. 40778–40787.

35. Li, J., Guo, Y., Schroeder, F.A., et al., Dopamine D2-Like Antagonists Induce Chromatin Remodeling in Striatal Neurons Through Cyclic AMP-Protein Kinase A and NMDA Receptor Signaling, J. Neurochem., 2004, vol. 90, pp. 1117–1131.

36. Thomassin, H., Flavin, M., Espinas, M.-L., et al., Glucocorticoid-Induced DNA Demethylation and Gene Memory during Development, EMBO J., 2001, vol. 20, pp. 1974–1983.

37. Kress, C., Thomassin, H., and Grange, T., Local DNA Demethylation in Vertebrates: How Could It Be Performed and Targeted?, FEBS Lett., 2001, vol. 494, pp. 135–140.

38. Irvine, R.A., Lin, I.G., and Hsieh, C.-L., DNA Methylation Has a Local Effect on Transcription and Histone Acetylation, Mol. Cell. Biol., 2002, vol. 22, no. 19, pp. 6689–6696.

39. Curradi, M., Izzo, A., and Badaracco, G., Molecular Mechanisms of Gene Silencing Mediated by DNA Methylation, Mol. Cell. Biol., 2002, vol. 22, no. 9, pp. 3157–3173.

40. Smet, Ch.De., Loriot, A., and Boon, T., Promoter-Dependent Mechanism Leading To Selective Hypomethylation within the 5′ Region of Gene MAGE—A1 in Tumor Cells, Mol. Cell. Biol., 2004, vol. 24, pp. 4781–4790.

41. Best, J.A., Chen, Y., Piech, K.M., et al., The Response of the Tyrosine Hydroxylase Gene To Cyclic AMP Is Mediated by Two Cyclic AMP Response Elements, J. Neurochem., 1995, vol. 65, pp. 1934–1943.

42. Sheng, M., McFadden, G., and Greenberg, M.E., Membrane Depolarization and Calcium Induce C-Fos Transcription Via Phosphorylation of Transcription Factor CREB, Neuron, 1990, vol. 4, pp. 571–582.

43. Okuse, K., Mizuno, N., Matsuoka, I., et al., Induction of Cholinergic and Adrenergic Differentiation in N-18 Cells by Differentiation Agents and DNA Demethylating Agents, Brain Res., 1993, vol. 626, pp. 225–233.

44. Aranyi, T., Faucheux, B.A., Khalfalla, O., et al., The Tissue-Specific Methylation of the Human Tyrosine Hydroxylase Gene Reveals New Regulatory Elements in the Firs Exon, J. Neurochem., 2005, vol. 94, pp. 129–139.

45. Vakhitova, Yu.V., Salimgareeva, M.Kh., and Seredenin, S.B., The Effect of Ladastene on the Activity of cAMP-Dependent Protein Kinases and Protein Phosphorylation in Rat Brain Cells, Eksper. Klinich. Farmakol., 2004, vol. 67, no. 3, pp. 7–9.

46. Vakhitova, Yu.V., Salimgareeva, M.Kh., and Seredenin, S.B., The Effect of Ladastene on Protein Kinase C Activity in Rat Brain Cells, Eksper. Klinich. Farmakol., 2004, vol. 67, no. 2, pp. 12–15.